Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin irritation / corrosion

Currently viewing:

Administrative data

Endpoint:
skin irritation: in vivo
Type of information:
other: risk assessment report
Adequacy of study:
weight of evidence
Study period:
may 2008
Reliability:
4 (not assignable)
Rationale for reliability incl. deficiencies:
other: Secondary litterature: European Union Risk Assessment Report DIPHENYLAMINE

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1977

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 404 (Acute Dermal Irritation / Corrosion)
Deviations:
not specified
GLP compliance:
not specified

Test material

Constituent 1
Chemical structure
Reference substance name:
Diphenylamine
EC Number:
204-539-4
EC Name:
Diphenylamine
Cas Number:
122-39-4
Molecular formula:
C12H11N
IUPAC Name:
diphenylamine

Results and discussion

In vivo

Results
Reversibility:
no data
Remarks on result:
other: no signs of irritation observed within a 7 days observation period

Applicant's summary and conclusion

Interpretation of results:
not irritating
Remarks:
Migrated information Criteria used for interpretation of results: not specified
Conclusions:
Diphenylamine caused no or only very slight skin irritation in tests with rabbits: Skin irritation potential of diphenylamine (no data on purity) was tested in the inner surface of the ears of two Albino rabbits by means of occlusive application of the substance for 24 hours (no information whether a vehicle was used or not used). There were no signs of irritation observed within a 7 days observation period.